9 Myths About Low Libido in Menopause That Keep Women From Effective Treatment for Years
The number of women who have spent years quietly convinced there was something wrong with them — their marriage, their mindset, their effort — when the answer was sitting in the research the whole time is genuinely heartbreaking. Low libido after a certain age is not a character flaw or a relationship verdict. It is biology, and biology can be addressed.
Learn more about Rose →Myth: Low Libido Is Just Psychological
While psychological factors can influence desire, the primary driver of low libido in menopause is hormonal. Declining estrogen, progesterone, and — critically — testosterone directly reduce genital sensitivity, lubrication, and the neurological signals that initiate sexual desire. Treating the physiology first is not dismissing the mind; it is addressing the root cause that is measurably present in the bloodstream.
Myth: Testosterone Is a Male Hormone and Has No Role in Women's Libido
Testosterone is produced in women's ovaries and adrenal glands throughout their lives and is the primary hormonal driver of sexual desire in women, not just men. Testosterone levels in women decline significantly across the menopause transition, and randomised controlled trials consistently show that testosterone therapy improves hypoactive sexual desire disorder (HSDD) in postmenopausal women. The Global Consensus Position Statement on testosterone for women, endorsed by major menopause societies worldwide, reflects this evidence unambiguously.
Myth: If You Are Not Stressed, Your Libido Would Come Back on Its Own
Stress reduction is genuinely useful for overall wellbeing, but telling a menopausal woman to simply relax ignores the physiological reality of hormone depletion. Even women in low-stress, stable, happy relationships experience significant loss of libido during the menopause transition because desire depends on hormonal signalling that stress management alone cannot restore. Blaming stress deflects from the real conversation about hormonal and medical interventions.
Myth: Low Libido Is Inevitable and Just Part of Ageing
Age alone does not eliminate sexual desire; hormone loss does, and hormone loss is not the same thing as ageing in an untreatable sense. Women who maintain adequate hormone levels — through natural variation or through hormone therapy — frequently report maintained or restored libido well into their fifties, sixties, and beyond. Framing low libido as inevitable ageing normalises a treatable condition and closes the door on solutions before the conversation has even started.
Myth: Genitourinary Symptoms Are Separate From Low Libido
Genitourinary syndrome of menopause (GSM) — which includes vaginal dryness, thinning tissues, and reduced lubrication — is physiologically inseparable from low libido for many women. When sex is uncomfortable or painful, the body and brain learn to associate it with pain, and desire predictably diminishes; this is a neurological loop, not a coincidence. Treating GSM with local oestrogen or ospemifene frequently restores willingness and desire independently of any psychological intervention.
Myth: Low Libido Only Matters If Your Partner Minds
Sexual wellbeing is a component of quality of life for women regardless of their relationship status, and the evidence shows that low libido causes personal distress — not just relational friction — in a significant proportion of women who experience it. The clinical definition of HSDD specifically includes personal distress as a criterion, meaning the problem belongs to the woman experiencing it, not her partner. Tying treatment decisions to a partner's preferences misframes whose health is actually being discussed.
Myth: HRT Will Automatically Fix Low Libido
Standard HRT containing oestrogen and progesterone is highly effective for many menopause symptoms, but it does not reliably restore libido on its own for women with low testosterone. Oestrogen improves vaginal tissue health and comfort, which helps, but desire itself is more directly governed by androgens. Women who start HRT and still experience low libido are not treatment failures — they may simply need the testosterone component of the conversation to begin.
Myth: Bringing It Up With a Doctor Is Embarrassing and Unlikely to Help
Studies consistently show that women do not raise sexual symptoms with healthcare providers, and providers do not ask about them — a silence that benefits no one. Evidence-based treatments for low libido in menopause, including testosterone therapy and local oestrogen for GSM, exist and are endorsed by major menopause and endocrinology societies globally. The embarrassment barrier is real, but it is worth pushing through: a well-informed clinician can offer options that genuinely change quality of life.
Myth: Testosterone Therapy Is Unsafe for Women
The safety profile of testosterone therapy for women, when used at physiological doses to restore levels to the normal premenopausal female range, is well-documented across multiple long-term studies. The primary side effects at appropriate doses are mild and usually reversible, including minor changes in body hair or skin, and cardiovascular and breast safety data at female-range doses are reassuring. The 2019 Global Consensus Position Statement, representing 11 major medical organisations, concluded that testosterone therapy at these doses is safe for postmenopausal women with HSDD.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.